Advertisement
Screener

Altamira Therapeutics Ltd. (CYTOF) Form 6-K: Report of foreign private issuer, 2023

0.8 / 5 stars · 6/40 Roast Me

Add as a preferred source on Google

Altamira Therapeutics Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-12-11: Form 6-K; Period of report 2023-12-11; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea189836-6k_altamira.htm.
  • 2023-12-11: Form 6-K; Period of report 2023-12-11; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea189613-6k_altamira.htm.
  • 2023-12-08: Form 6-K; Period of report 2023-12-08; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea189714-6k_altamira.htm.
  • 2023-11-22: Form 6-K; Period of report 2023-11-22; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea188939-6k_altamira.htm.
FiledFormPeriod of reportDescriptionDocument
2023-12-116-K2023-12-11REPORT OF FOREIGN PRIVATE ISSUERea189836-6k_altamira.htm
2023-12-116-K2023-12-11REPORT OF FOREIGN PRIVATE ISSUERea189613-6k_altamira.htm
2023-12-086-K2023-12-08REPORT OF FOREIGN PRIVATE ISSUERea189714-6k_altamira.htm
2023-11-226-K2023-11-22REPORT OF FOREIGN PRIVATE ISSUERea188939-6k_altamira.htm
2023-11-216-K2023-11-21REPORT OF FOREIGN PRIVATE ISSUERea188701-6k_altamira.htm
2023-10-316-K2023-10-31REPORT OF FOREIGN PRIVATE ISSUERea187463-6k_altamira.htm
2023-10-046-K2023-10-04REPORT OF FOREIGN PRIVATE ISSUERea186227-6k_altamirather.htm
2023-09-126-K2023-06-30REPORT OF FOREIGN PRIVATE ISSUERea184690-6k_altamirather.htm
2023-08-216-K/A2022-06-30AMENDMENT NO. 1 TO FORM 6-Kea183250-6ka1_altamira.htm
2023-07-286-K2023-07-28CURRENT REPORTea182469-6k_altamirather.htm
2023-07-266-K2023-07-26REPORT OF FOREIGN PRIVATE ISSUERea182317-6k_altamirathera.htm
2023-07-116-K2023-07-11REPORT OF FOREIGN PRIVATE ISSUERea181589-6k_altamira.htm
2023-07-056-K2023-07-03REPORT OF FOREIGN PRIVATE ISSUERea181306-6k_altamira.htm
2023-06-306-K2023-06-30REPORT OF FOREIGN PRIVATE ISSUERea181132-6k_altamira.htm
2023-06-276-K2023-06-27CURRENT REPORTea181023-6k_altamira.htm
2023-06-156-K2023-06-15REPORT OF FOREIGN PRIVATE ISSUERea180434-6k_altamirathera.htm
2023-05-306-K2023-05-30REPORT OF FOREIGN PRIVATE ISSUERea179273-6k_altamira.htm
2023-05-266-K2023-05-26REPORT OF FOREIGN PRIVATE ISSUERea179368-6k_altamira.htm
2023-05-166-K2023-05-16REPORT OF FOREIGN PRIVATE ISSUERea178709-6k_altamira.htm
2023-05-026-K2023-05-02REPORT OF FOREIGN PRIVATE ISSUERea177806-6k_altamira.htm
2023-04-186-K2023-04-18REPORT OF FOREIGN PRIVATE ISSUERea177096-6k_altamira.htm
2023-04-136-K2023-04-13REPORT OF FOREIGN PRIVATE ISSUERea176901-6k_altamira.htm
2023-04-036-K2023-04-03REPORT OF FOREIGN PRIVATE ISSUERea176340-6k_altamira.htm
2023-03-096-K2023-03-09CURRENT REPORTea174957-6k_altamira.htm
2023-02-176-K2023-02-17REPORT OF FOREIGN PRIVATE ISSUERea173819-6k_altamira.htm
2023-01-276-K2023-01-27REPORT OF FOREIGN PRIVATE ISSUERea172272-6k_altamira.htm
2023-01-246-K2023-01-24REPORT OF FOREIGN PRIVATE ISSUERea172111-6k_altamira.htm
Advertisement